John Neis insider trades: Cellectar Biosciences (CLRB) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
11 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | CLRB | ↓ Sell | 198 | $3.70 | $732 | Indirect | Dec 16, 2025 (4d) |
| Nov 14, 2017 | CLRB | ↓ Sell | 5,214 | $1.49 | $8K | Indirect | Nov 16, 2017 (2d) |
| Nov 29, 2016 | CLRB | ↑ Buy | 333,333 | $1.49 | $497K | Indirect | Nov 30, 2016 (1d) |
| Apr 20, 2016 | CLRB | ↑ Buy | 234,742 | $2.12 | $498K | Indirect | Apr 21, 2016 (1d) |
| Aug 20, 2014 | CLRB | ↑ Buy | 268,711 | $3.75 | $1.0M | See Foonote | Aug 22, 2014 (2d) |
| Mar 14, 2008 | TOMO | ↓ Sell | 125,000 | $13.23 | $1.7M | Held by Advantage Capital Wisconsin Part | Mar 14, 2008 (0d) |
| Feb 26, 2008 | TOMO | ↓ Sell | 34,554 | $14.53 | $502K | Held by Advantage Capital Wisconsin Part | Feb 28, 2008 (2d) |
| Oct 16, 2007 | TTPY | ↓ Sell | 1,336,904 | $22.25 | $29.7M | Held by Venture Investors Early Stage Fu | Oct 18, 2007 (2d) |
| Oct 16, 2007 | TTPY | ↓ Sell | 426,700 | $22.25 | $9.5M | Held by Advantage Capital Wisconsin Part | Oct 18, 2007 (2d) |
| May 14, 2007 | TTPY | ↓ Sell | 742,424 | $19.00 | $14.1M | Indirect | May 15, 2007 (1d) |
| Nov 8, 2005 | TWTI | ↑ Buy | 5,000 | $2.68 | $13K | Direct | Nov 9, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CLRB insiders
Open-market trades in the last 12 months
About John Neis's insider trades
John Neis is a director at Cellectar Biosciences (CLRB). Since Nov 8, 2005, John has reported 4 open-market purchases worth $2.0M and 7 sales worth $55.5M on SEC Form 4. In the last 12 months: 1 sale ($732).
Their filings also include grants and awards (14 filings), other transactions (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CLRB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.